Regulatory Developments

03a_RegNews_Alternate_770x2953.jpg

Regulatory Developments

FDA guidance on REMS, ANDA pathways, pharmaceuticals/M4 organization of common technical document, and notices on inventions available for licensing.

Related Stories

Table of Contents
December 2017